跳至主要内容
临床试验/NCT07400471
NCT07400471招募中1 期

The Effects of Preemptive Multimodal Analgesic on Endodontic Pain.

Chattogram International Dental College1 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2026年2月6日最近更新:
干预措施

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
280
试验地点
1
主要终点
Effects of Preemptive multimodal analgesia on post endodontic pain

研究概览

简要总结

A clinical trial comparing preemptive multimodal analgesics with placebo in the management of immediate and chronic post-endodontic pain. The study utilizes statistical methods such as chi-squared, T-tests, and regression analysis, accounting for multiple outcomes with the Bonferroni adjustment. Duloxetine hydrochloride and pregabalin, both available in Bangladesh, are evaluated as experimental drugs, while placebos are used to assess psychological effects on pain. All participants receive standard interventional treatments, with acetaminophen provided as needed, and ethical considerations are addressed according to international guidelines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Consequently, triple binding is ensured (by the sit investigator, patient, and operator). The statistician in charge of the data analysis will also be blind.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient's aged 18 years more.
  • ASA physical status I-II.
  • Patient with the complain of pain originated from teeth and surrounding structure.
  • Preoperative pain severity is moderate to severe.
  • Patient can be able to make communication about their pain.
  • Patients give consent to attain this research.
  • Patients have others concomitant chronic pain.
  • Patients who will have non-surgical endodontic treatment.
  • Patients who will have non-surgical endodontic retreatment.
  • Patients who will have surgical endodontic treatment.

排除标准

  • Patient would not like to attain in research.
  • Patients have any medical condition those are contra indication for study drug.
  • ASA physical status III, IV, V.
  • Patient already under treated any anti convulsent drug.
  • Patient participant in other clinical trials.
  • Lack of motivation or poor adharence to study protocols.
  • Patient with Pregnancy
  • Severe organ dysfunction
  • Patient have Hepatitis B, and other cross infection disease like (HIV)
  • Uncontrolled comorbidities that patient do not fit for endodontic treatment.
  • Severe cognitive impaired patients.
  • History of certain cancers or severe hematological issues.

研究组 & 干预措施

Multimodal Analgesia

Active Comparator

Preemptive Multi modal analgesic drug: Experimental group will be divided into 2 subgroups according to use of drug.

A. Pregabalin-acetaminophen. B. Duloxetine-Acetaminophen Pregabalin-acetaminophen: Before a half-hour endodontic treatment, patients in this group will receive a single dosage of 50 mg pregabalin and 500 mg acetaminophen. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Duloxetine-Acetaminophen: Prior to a half-hour endodontic treatment, patients in this group will receive a single dosage of 500 mg of acetaminophen and 30 mg of Duloxetine. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

干预措施: Pregabalin- Acetaminophen (Drug)

Multimodal Analgesia

Active Comparator

Preemptive Multi modal analgesic drug: Experimental group will be divided into 2 subgroups according to use of drug.

A. Pregabalin-acetaminophen. B. Duloxetine-Acetaminophen Pregabalin-acetaminophen: Before a half-hour endodontic treatment, patients in this group will receive a single dosage of 50 mg pregabalin and 500 mg acetaminophen. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Duloxetine-Acetaminophen: Prior to a half-hour endodontic treatment, patients in this group will receive a single dosage of 500 mg of acetaminophen and 30 mg of Duloxetine. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

干预措施: Duloxetine- Acetaminophen (Drug)

Control

Placebo Comparator

Placebo: Patient in this group will receive placebo drug before half an hour of operating procedure. If necessary, acetaminophen dosages of 500 mg will be administered three times a day and noted

干预措施: Pregabalin- Acetaminophen (Drug)

Control

Placebo Comparator

Placebo: Patient in this group will receive placebo drug before half an hour of operating procedure. If necessary, acetaminophen dosages of 500 mg will be administered three times a day and noted

干预措施: Duloxetine- Acetaminophen (Drug)

结局指标

主要结局

Effects of Preemptive multimodal analgesia on post endodontic pain

时间窗: 6, 12, 24, 48, 72 hours

Primary Pain during endodontic treatment and the effectiveness of intervention will be evaluated at 6, 12, 24, 48, 72, and hourly intervals after the endodontic procedure. Treatment-related anaesthetic efficacy will be assessed using the VAS (Visual Analogue Scale; numerical value 0-10). During endodontic treatment, the level of pain will decide how effective the anesthetic is. The patient will be asked to rate the analgesic effects on a VAS (Visual Analogue Scale) scale by providing a numerical number 0-10. '0" are indicated no pain, 1-3= mild pain, 4-6= moderate pain, 7-10= sever pain.

次要结局

  • Mechanical Detection Threshold(baseline, 72 hours)
  • Mechanical Pain Threshold(baseline, 72 hours)
  • Mechanical Pain Sensitivity(baseline, 72 hours)

研究者

发起方
Chattogram International Dental College
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Md. Abu Saeed Ibn Harun

Professor

Chattogram International Dental College

研究点 (1)

Loading locations...

相似试验